BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 9, 2008
View Archived Issues
Increased gastrointestinal motility with Elixir's novel ghrelin receptor agonist
Read More
LGD-2941 well tolerated, orally bioavailable in healthy subjects
Read More
Novel histamine H3 receptor inverse agonist profiled at Banyu
Read More
Novartis acquires 25% stake in Alcon as part of definitive agreement with Nestle
Read More
Inovio and VGX sign merger agreement
Read More
Medivation reports positive results from phase II study of Dimebon in HD
Read More
Provectus treats first 25% of melanoma subjects in phase II clinical trial of PV-10
Read More
Phase I study explores DNA-hsp65 immunotherapy in head and neck cancer
Read More
Sendai virus vaccines protect against parainfluenza and respiratory syncytial viruses in vivo
Read More
GeoVax to initiate phase II human trials with preventative AIDS vaccine
Read More
Light Sciences Oncology begins clinical trials of Litx therapy in patients with BPH
Read More
Novel agents for treating HCV infection disclosed in recent Genelabs patents
Read More
Seattle Genetics enters into antibody-drug conjugate collaboration with Daiichi Sankyo
Read More
Recent patents describe new treatment options for endocrine-related disorders
Read More
Anadys receives clearance in the Netherlands for phase I clinical trial of ANA-773
Read More
New antithrombotic agents divulged in recent patent literature
Read More
Sciele Pharma completes phase III safety trial for glycopyrrolate and plans to file an NDA
Read More
Pharmasset initiates combination study of clevudine and Viread for HBV
Read More
TIPO-4 extension study confirms tesofensine's efficacy in weight management
Read More
Teva reports results from phase III FORTE study of glatiramer acetate 40 mg in RRMS
Read More
Tumor-targeted Rexin-G receives FDA orphan drug designation for osteosarcoma
Read More
Immatics receives research grants for cancer research totaling EUR 1.4 million
Read More
FoldRx discovers series of novel drug prototypes for treatment of cystic fibrosis
Read More
Amorfix on schedule to complete antibody infusion studies in mice of therapy for ALS
Read More
